Correlation Between Apellis Pharmaceuticals and Prothena Plc
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Prothena Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Prothena Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Prothena plc, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Prothena Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Prothena Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Prothena Plc.
Diversification Opportunities for Apellis Pharmaceuticals and Prothena Plc
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Apellis and Prothena is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Prothena plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prothena plc and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Prothena Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prothena plc has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Prothena Plc go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Prothena Plc
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 0.94 times more return on investment than Prothena Plc. However, Apellis Pharmaceuticals is 1.07 times less risky than Prothena Plc. It trades about 0.17 of its potential returns per unit of risk. Prothena plc is currently generating about -0.21 per unit of risk. If you would invest 2,958 in Apellis Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of 442.00 from holding Apellis Pharmaceuticals or generate 14.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Prothena plc
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Prothena plc |
Apellis Pharmaceuticals and Prothena Plc Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Prothena Plc
The main advantage of trading using opposite Apellis Pharmaceuticals and Prothena Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Prothena Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prothena Plc will offset losses from the drop in Prothena Plc's long position.| Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
| Prothena Plc vs. Equillium | Prothena Plc vs. DiaMedica Therapeutics | Prothena Plc vs. Valneva SE ADR | Prothena Plc vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Correlations Find global opportunities by holding instruments from different markets |